SyMap
Latest round
- Series E
Last raised
- Dec 2021
Total raised
- $135M
Investors
- 11
About SyMap
Based in Suzhou, China and established in 2012, SyMap is a medical equipment developer that focuses on developing ablation catheter and supporting frequency ablation instrument for the treatment of hypertension and related cardiovascular diseases. The company founder is Jie Wang, who served as Dean of School of Medicine of Nanjing University, Executive Vice Dean of Research Institute of Jiangsu Provincial School of Clinical Medicine. In 2014, it obtained the NMPA medical device production enterprise license. In 2020, the company's hypertension/asthma clinical trials progressed in phases. The bronchial radiofrequency ablation system passed the NMPA special approval application for innovative medical devices. The company developed two products, renal nerve ablation system for hypertension, and bronchial radiofrequency ablation system for severe asthma. Theses products are carrying out clinical registration trials, and have entered National Medical Products Administration (NMPA ) special review process for innovative medical devices.
Who invested in SyMap
11 investors across 6 rounds
See all investors in SyMap
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SyMap
Who invested in SyMap?
SyMap has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SyMap raised?
SyMap has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did SyMap last raise money?
SyMap's most recent round on record is a Series E, in Dec 2021.
What does SyMap do?
Based in Suzhou, China and established in 2012, SyMap is a medical equipment developer that focuses on developing ablation catheter and supporting frequency ablation instrument for the treatment of hypertension and related cardiovascular diseases.
Where is SyMap headquartered?
SyMap is headquartered in Suzhou, China.
Which VCs invest in companies like SyMap?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at SyMap's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series E
Raising like SyMap? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.